InvestorsHub Logo
Followers 5
Posts 265
Boards Moderated 0
Alias Born 04/13/2013

Re: None

Tuesday, 05/16/2017 7:40:09 AM

Tuesday, May 16, 2017 7:40:09 AM

Post# of 1445
Hello board. I'm new to Biotime and just starting out my DD.

I was an unfortunate investor in Ocata therapeutics and Advance Cell Technologies before that. I loved the tech, loved the IP. And they seemed to be getting near miraculous results from their early stage RPE program before being bought. For what I believed to be far too little.

Anyone on this board familiar with that situation? Is this the same pluripotent cell tech. Did the IP stick with Dr. West? Am I missing a connection?

I loved all limitless potential of OCAT. But they struggled with financing and arguably some poor management.

Anyone familiar with both situations have anything to add?

Thanks so much in advance. Looking forward to learning more about this company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News